Royal Philips is adding another remote-monitoring platform to its portfolio with its planned acquisition of Cardiologs. The Paris-based company uses ECG data to detect potential cardiac arrhythmias.

CAMBRIDGE, Mass. – Royal Philips (NYSE: PHG, AEX: PHIA) a global leader in health technology, today announced a collaboration with Epic to integrate Philips’ suite of cardiac ambulatory monitoring and ...

Empowering clinical teams to respond to surges, track usage and ease workflows with user-friendly touchscreen technology for telemetry patients on the move Telemetry overuse can burden frontline teams ...

Amsterdam, the Netherlands – Royal Philips (NYSE: PHG, AEX: PHIA), a global leader in health technology, today highlighted how it integrates AI in cardiac ultrasound and across cardiac care to help ...

Philips plans to purchase a remote cardiac diagnostics and monitoring technology company for $2.8 billion. 1. On Dec. 18, Philips announced plans to acquire BioTelemetry, a company with technology ...

Three studies demonstrate how Philips MCOT wearable ambulatory monitoring ECG and proprietary AI models applied to ECG digital biomarkers can help to improve diagnosis, reduce readmissions, and lower ...

In this episode, we dive deep into the cutting-edge world of cardiac care with Nick Wilson, Business Leader for Philips Ambulatory Monitoring and Diagnostics. Nick shares his insights on the pressing ...

Philips will now offer the largest cardiac care portfolio through Epic’s Aura platform CAMBRIDGE, Mass. – Royal Philips (NYSE: PHG, AEX: PHIA) a global leader in health technology, today announced a ...